Deprecated: Function WP_Dependencies->add_data() was called with an argument that is deprecated since version 6.9.0! IE conditional comments are ignored by all supported browsers. in /home/foxlogica/public_html/psx/wp-includes/functions.php on line 6131
⏸️ POL: NEUTRAL Signal (5/10) - TRADING IN SHARES OF COMPANY - FoxLogica

⚡ Flash Summary

On October 7, 2025, Pakistan Oilfields Limited (POL) announced the disclosure of interest regarding share transactions by relevant persons holding company shares, as per PSX Regulation 5.6.4. Mr. Mehboob ur Rehman, Executive Finance, executed a transaction involving the sale of 2,000 shares at a rate of 737.72. This transaction resulted in a cumulative shareholding of 776 shares. The transaction will be presented in a subsequent board meeting for consideration, and the holding period is confirmed to be over six months, complying with regulatory requirements.

Signal: NEUTRAL ⏸️
Strength: 5/10
Sentiment: NEUTRAL
Time Horizon: MEDIUM_TERM

📌 Key Takeaways

  • 📝 Mr. Mehboob ur Rehman, Executive Finance, sold 2,000 shares of Pakistan Oilfields Limited.
  • 📅 The transaction was executed on October 6, 2025.
  • 💸 The sale rate was 737.72 per share.
  • 📊 The cumulative shareholding after the transaction is 776 shares.
  • 📜 The transaction adheres to PSX Regulation 5.6.4.
  • 🏢 The transaction will be presented in the subsequent board meeting for consideration.
  • ⏳ The holding period for the transaction is confirmed to be over six months.
  • ✅ Compliance with Section 105 of the Securities Act, 2015 is ensured.
  • 🏦 If the holding period is less than six months, the equivalent profit will be deposited with SECP.
  • 📢 The transaction has been intimated to PSX.
  • 📄 Shares are held in CDC form.
  • 🚦 Market for the transaction was ‘Ready’.

🎯 Investment Thesis

HOLD. The announcement of an executive selling shares does not provide a compelling reason to change the investment thesis. While insider transactions can sometimes signal shifts in company outlook, this isolated event does not offer sufficient evidence. A neutral stance is appropriate, pending further developments or financial results. Price target and time horizon remain unchanged until more significant information becomes available.

View Original PDF

Disclaimer: AI-generated analysis. Not financial advice.

Leave a Comment